Clinical Trials Directory

Trials / Completed

CompletedNCT03052660

Impact of Preoperative Midazolam on Outcome of Elderly Patients

Impact of Preoperative Midazolam on Outcome of Elderly Patients: a Multicentre Randomised Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
782 (actual)
Sponsor
RWTH Aachen University · Academic / Other
Sex
All
Age
65 Years – 80 Years
Healthy volunteers
Not accepted

Summary

We aim to assess, if placebo compared to preoperative administration of midazolam in elderly patients is equal in regard to the global postoperative patient satisfaction

Detailed description

Generalised premedication with benzodiazepines in all surgical patients has become questionable, regarding the risk-benefit assessment and the lack of evidence for this practice. Particularly, in elderly patients (≥65 years), a higher risk for adverse events is described. Patients will be randomly assigned to one of the following two study groups. Preoperatively, group 1 will receive midazolam and group 2 will receive placebo. Anaesthesia will be performed according to the clinical routine. All possible side effects are described in the SmPC for midazolam. For the placebo-group, we do not expect any harm, as in the case of strong preoperative anxiety or agitation, additional midazolam application may occur on behalf of the attending anaesthesist at any time. The sample size was calculated based on detecting a minimum of 5 unit difference in the primary outcome variable overall patient satisfaction measured with the EVAN-G. Setting a type 1 error of 0.05, a power of 0.8 and assuming the standard deviation of EVAN-G to be 14 units, 248 patients per group are needed to detect a 5 unit difference. Considering a drop-out of 10% and a screening failure of 10%, we decided to include 614 patients in total. The hypothesis of the study is that global patient satisfaction after surgery in elderly patients is similar after preoperative placebo application compared to midazolam application.

Conditions

Interventions

TypeNameDescription
DRUGMidazolamOral administration preoperatively
DRUGPlacebo oral capsuleOral administration preoperatively

Timeline

Start date
2017-10-12
Primary completion
2019-06-24
Completion
2019-06-24
First posted
2017-02-14
Last updated
2019-11-18

Locations

9 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT03052660. Inclusion in this directory is not an endorsement.